PROVIDER PROFILE · NPI 1609890623
John SweetMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
181
Unique beneficiaries
—
Total services
2,168
Distinct HCPCS
7
Medicare payment
$23K
Peer benchmark
Total Medicare services vs. 62 Allergy/ Immunology providers in MN — top quintile (cohort median 1,488).
PRESCRIBING · PART D · 2024
Total Rx claims
844
Beneficiaries
—
Total drug cost
$323K
Distinct drugs
14
Brand share
31.8%
Top prescribed drugs
Levocetirizine Dihydrochloride184 claims
Fluticasone Propionate131 claims
Montelukast Sodium122 claims
Fluticasone/Umeclidin/Vilanter66 claims
Mometasone/Formoterol51 claims
QUALITY · MIPS · 2024
Final MIPS score
92.7
Quality
74.5
Cost
72.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.74%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where John Sweet's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Hennepin Healthcare System, Inc Opioid Treatment Program · Minneapolis, MN | 73 | 3,028 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE